AXIM Biotechnologies Competitors and Similar CompaniesClear all

AXIM Biotechnologies's competitors and similar companies include Kaya Holdings and Zynerba.
AXIM Biotechnologies
AXIM Biotechnologies
AXIM Biotechnologies is a company focused on the research, development, and production of cannabis-based pharmaceutical, nutraceutical, and cosmetic products.
Kaya Holdings
Kaya Holdings
Kaya Holdings owns and operates brands that produce, distribute and sell premium cannabis products, including flower, concentrates, and cannabis-infused baked goods and candies.
Zynerba
Zynerba
Zynerba Pharmaceuticals is a company developing transdermally-delivered cannabinoid therapeutics for patients affected by rare and near-rare neuropsychiatric conditions.
Founding Date
Founding Date
2010
Founding Date
1993
Founding Date
2014
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
New York, US HQ
San Diego, US
Locations
Fort Lauderdale, US HQ
Kallithea, GR
Tzur Yitzhak, IL
Locations
Devon, US HQ
Employees
Employees
6
Employees
620% increase
Employees
2511% decrease
Valuation ($)
Valuation ($)
1.5 m
Valuation ($)
1 m
Valuation ($)
70.1 m

Financial

Revenue (est.)
Revenue (est.)
$39.5k (FY, 2023)
Revenue (est.)
$7.1k (FY, 2024)
Revenue (est.)
N/A
Net income
Net income
($8.1m) (FY, 2023)
Net income
($2.2m) (FY, 2024)
Net income
($35m) (FY, 2022)

Funding

Total funding raised
Total funding raised
$ 115k
Total funding raised
N/A
Total funding raised
$ 16.5m
For sources of this data, please see the company profile

View Company Profiles

Kaya Holdings
HQ
Fort Lauderdale, US
Employees
6↑ 20% increase

Kaya Holdings owns and operates brands that produce, distribute and sell premium cannabis products, including flower, concentrates, and cannabis-infused baked goods and candies.

View company
Zynerba
HQ
Devon, US
Employees
25↓ 11% decrease

Zynerba Pharmaceuticals is a company developing transdermally-delivered cannabinoid therapeutics for patients affected by rare and near-rare neuropsychiatric conditions.

View company